Puma Biotechnology Inc (PBYI) — Free Cash Flow Yield
Biotech & Pharma
| Metric | Value |
|---|---|
| FCF Yield | 7.2% |
| Biotech & Pharma Sector Avg FCF Yield | 14.3% |
| Annual Free Cash Flow | $41M |
| Market Cap | $569M |
| P/E Ratio | 21.2x |
Puma Biotechnology Inc's FCF yield of 7.2% is below the Biotech & Pharma sector average (14.3%).
Frequently Asked Questions
What is Puma Biotechnology Inc's (PBYI) free cash flow yield?
Puma Biotechnology Inc's (PBYI) free cash flow yield is 7.2%. That is below the Biotech & Pharma sector average (14.3%).
Is PBYI's free cash flow yield good?
At 7.2%, PBYI's free cash flow yield is considered good — yields above 10% are generally excellent, 7–10% good, 4–7% fair, and below 4% weak, though context varies by sector and growth stage.
How much free cash flow does Puma Biotechnology Inc generate?
Puma Biotechnology Inc generated $41M in free cash flow, against a market cap of $569M.
How is free cash flow yield calculated?
Free cash flow yield = (Free Cash Flow ÷ Market Capitalization) × 100%. Free cash flow equals operating cash flow minus capital expenditures.
Data from public filings. Not investment advice. Calculate your own FCF yield →